Comunicados Internacional29 marCOMUNICADO: Grünenthal and NovaQuest enter agreement to advance the resiniferatoxin Phase III program in osteoarthritis
Comunicados Internacional07 marCOMUNICADO: Grünenthal donates 400.000€ and provides pain treatment medicine to Ukraine